47 hedge funds and large institutions have $12.9M invested in BioVie in 2023 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 15 increasing their positions, 6 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding:

0.01% more ownership

Funds ownership: 0.04%0.05% (+0.01%)

1% less call options, than puts

Call options by funds: $558K | Put options by funds: $564K

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
47
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$558K
Puts
$564K
Net Calls
Net Calls Change

Top Buyers

1 +$2.82M
2 +$1.56M
3 +$1.02M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$889K
5
BFM
Boothbay Fund Management
New York
+$510K

Top Sellers

1 -$2.31M
2 -$742K
3 -$143K
4
6CM
683 Capital Management
New York
-$125K
5
FIA
FNY Investment Advisers
New York
-$110K
Name Holding Trade Value Shares
Change
Change in
Stake
26
$125K
27
$114K
28
$64.3K
29
$45K
30
$44.6K
31
$35K
32
$27.5K
33
$22.7K
34
$20.7K
35
$12.9K
36
$8.08K
37
$8.08K
38
$8.08K
39
$5.86K
40
$4.73K
41
$4K
42
$2.86K
43
$2.42K
44
$2.42K
45
$2.42K
46
$1.62K
47
$808
48
$131
49
50